A multiprotein complex consisting of the cellular coactivator p300, AP- 1/ATF, as well as NF-κB is responsible for the activation of the mouse major histocompatibility class I (H-2Kb) enhancer A

Gene Expression

Volumn 8, Issue 1, 1999, Pages 1-18

  Brockmann, Dieter ^a   Pützer, Brigitte M ^a   Lipinski, Kai S ^a   Schmücker, Ulla ^a   Esche, Helmut ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

AP 1 ATF; MHC class I; NF B; p300

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSCRIPTION FACTOR AP 1;

ARTICLE; ENHANCER REGION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PROMOTER REGION; PROTEIN ANALYSIS;

ACTIVATING TRANSCRIPTION FACTORS; ANIMALS; BLOOD PROTEINS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CREB-BINDING PROTEIN; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; H-2 ANTIGENS; HELA CELLS; HUMANS; MICE; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

ENA;

EID: 0033043560     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Ackrill, A. M.; Blair, G. E. Nuclear proteins binding to an enhancer element of the major histocompatibility class I promoter: Differences between highly oncogenic and nononcogenic adenovirus-transformed rat cells. Virology 172:643-646; 1989.
2. Angel, P.; Imagawa, M.; Chiu, R.; Stein, B.; Imbra, R. J.; Rahmsdorf, H. J.; Jonat, C.; Herrlich, P.; Karin, M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739; 1987.
3. Auwerx, J.; Sassone-Corsi, P. IP-1: A dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation. Cell 64:983-993; 1991.
4. b class I major histocompatibility gene. Mol. Cell. Biol. 7:305-313; 1987.
5. Baldwin, A. S. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14:649-681; 1996.
6. Boshart, M.; Klüppel, M.; Schmidt, A.; Schütz, G.; Luckow, B. Reporter constructs with low background activity utilizing the CAT gene. Gene 110:129-130; 1992.
7. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254; 1976.
8. Brockmann, D.; Feng, L.; Kröner, G.; Tries, B.; Esche, H. Adenovirus type 12 early region 1A expresses a 52R protein repressing the trans-activating activity of transcription factor c-Jun/AP-1. Virology 198:717-723; 1994.
9. b) activity by the adenovirus type 12-unique 52R E1A protein. Oncogene 12:1715-1725; 1996.
10. Burke, P. A.; Hirschfeld, S.; Shirayoshi, Y.; Kasik, J. W.; Hamada, K.; Apella, E.; Ozato, K. Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene. J. Exp. Med. 169:1309-1321; 1989.
11. Carey, M. The enhanceosome and transcriptional synergy. Cell 92:5-8; 1998.
12. Cereb, N.; Yang, S. Y. The regulatory complex of HLA class I promoters exhibits locus-specific conservation with limited allelic variation. J. Immunol. 152: 3873-3883; 1994.
13. David-Watine, B.; Israel, A.; Kourilsky, P. The regulation and expression of MHC class I genes. Immunol. Today 11:286-292; 1990.
14. Dey, A.; Thornton, A. M.; Lonergan, M.; Weissman, S. M.; Chamberlain, J. W.; Ozato, K. Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol. Cell. Biol. 12:3590-3599; 1992.
15. Du, W.; Thanos, D.; Maniatis, T. Mechanism of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74:887-898; 1993.
16. Ehrlich, R.; Maguire, J. E.; Singer, D. S. Identification of negative and positive regulatory elements associated with a class I major histocompatibility complex gene. Mol. Cell. Biol. 8:695-703; 1988.
17. Foletta, V. Transcription factor AP-1, and the role of Fra-2. Immunol. Cell Biol. 74:121-133; 1996.
18. Fried, M.; Crothers, D. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9:6505-6525; 1981.
19. Garner, M.; Revzin, A. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: Application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9:3047-3060; 1981.
20. Gerritsen, M. E.; Williams, A. J.; Neish, A. S.; Moore, S.; Shi, Y.; Collins, T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94:2929-2932; 1997.
21. Giuliani, C.; Saji, M.; Napolitano, G.; Palmer, L. A.; Taniguchi, S.-I.; Shong, M.; Singer, D. S.; Kohn, L. D. Hormonal modulation of major histocompatibility complex class I gene expression involves an enhancer A-binding complex consisting of Fra-2 and the p50 subunit of NF-κB. J. Biol. Chem. 270:11453-11462; 1995.
22. Gorman, C. M.; Moffat, L. F.; Howard, B. H. Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051; 1982.
23. Hamada, K.; Gleason, S. L.; Levi, B.-Z.; Hirschfeld, S.; Appella, E.; Ozato, K. H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc. Natl. Acad. Sci. USA 86:8289-8293; 1989.
24. d expression. J. Biol. Chem. 272:15993-16001; 1997.
25. Israel, A.; Kimura, A.; Kieran, M.; Yano, O.; Kanellopoulos, J.; Le Bail, O.; Kourilsky, P. A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and β2-microglobulin. Proc. Natl. Acad. Sci. USA 84:2653-2657; 1987.
26. Israël, A.; Le Bail, O.; Hatat, D.; Piette, J.; Kieran, M.; Logeat, F.; Wallach, D.; Fellous, M.; Kourilsky, P. TNF stimulates expression of mouse MHC class I genes by inducing an NF-κB-like enhancer binding activity which displaces constitutive factors. EMBO J. 8: 3793-3800; 1989.
27. Israël, A.; Yano, O.; Logeat, F.; Kieran, M.; Kourilsky, P. Two purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: One of them is a positive regulator induced upon differentiation of teratocarcinoma cells. Nucleic Acids Res. 17: 5245-5257; 1989.
28. Karin, M.; Liu, Z.-G.; Zandi, E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240-246; 1997.
29. Kim, T. K.; Maniatis, T. The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome. Mol. Cell 1:119-129; 1997.
30. b promoter: Enhancer-like sequences and their role in the regulation of class I gene expression. Cell 44:261-272; 1986.
31. Korber, B.; Mermod, N.; Hood, L.; Stroynowski, I. Regulation of gene expression by interferons: Control of H-2 promoter responses. Science 239:1302-1306; 1988.
32. Laemmli, E. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685; 1970.
33. Lipinski, K. S.; Esche, H.; Brockmann, D. Amino acids 1-29 of the adenovirus serotypes 12 and 2 E1A proteins interact with rap30 (TFIIF) and TBP in vitro. Virus Res. 54:99-106; 1998.
34. Liu, X.; Ge, R.; Westmorland, S.; Cooney, A. J.; Tsai, S. Y.; Tsai, M.-J.; Ricciardi, R. P. Negative regulation by the R2 element of the MHC class I enhancer in adenovirus-12 transformed cells correlates with high levels of COUP-TF binding. Oncogene 9:2183-2190; 1994.
35. Liu, X.; Ge, R.; Ricciardi, R. P. Evidence for the involvement of a nuclear NF-κB inhibitor in global down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells. Mol. Cell. Biol. 16:398-404; 1996.
36. Maniatis, T.; Sambrook, I.; Fritsch, E. F. Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
37. 2, of the HLA-A class I regulatory complex is an essential part of the promoter. J. Immunol. 153:5082-5090; 1994.
38. Merika, M.; Williams, A. J.; Chen, G.; Collins, T.; Thanos, D. Recruitment of CBP/p300 by the IFNβ enhanceosome is required for synergistic activation of transcription. Mol. Cell 1:277-289; 1998.
39. Moran, E. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3:63-70; 1993.
40. Nabholz, M.; MacDonald, H. R. Cytolytic T lymphocytes. Annu. Rev. Immunol. 1:273-306; 1983.
41. Sanger, F.; Nicklen, S.; Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467; 1977.
42. Schouten, G. J.; Van der Eb, A. J.; Zantema, A. Down-regulation of MHC class I expression due to interference with p105-NFκB1 processing by Ad12E1A. EMBO J. 14:1498-1507; 1995.
43. Segars, J. H.; Nagata, T.; Bours, V.; Medin, J. A.; Franzoso, G.; Blanco, J. C. G.; Drew, P. D.; Becker, K. G.; An, J.; Tang, T.; Stephany, D. A.; Neel, B.; Siebenlist, U.; Ozato, K. Retinoic acid induction of major histocompatibility complex class I genes in NT-era-2 embryonal carcinoma cells involves induction of NF-κB (p50-p65) and retinoic acid receptor β-retinoid X receptor β heterodimers. Mol. Cell. Biol. 13:6157-6169; 1993.
44. Shapiro, D. L.; Sharp, P. A.; Wahli, W. W.; Keller, M. J. A high-efficient HeLa cell nuclear transcription extract. DNA 7:47-55; 1988.
45. Shirayoshi, Y.; Miyazaki, J.; Burke, P. A.; Hamada, K.; Appella, E.; Ozato, K. Binding of multiple factors to the 5′upstream regulatory element of the murine major histocompatibility class I gene. Mol. Cell. Biol. 7: 4542-4548; 1987.
46. Singer, D. S.; Maguire, J. E. Regulation of the expression of class I MHC genes. Crit. Rev. Immunol. 10: 235-257; 1990.
47. Stein, B.; Baldwin, A. S.; Ballard, D. W.; Greene, W. C.; Angel, P.; Herrlich, P. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879-3891; 1993.
48. Suzuki, T.; Okuno, H.; Yoshida, T.; Endo, T.; Nishina, H.; Iba, H. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19:5537-5542; 1991.
49. Thanos, D.; Maniatis, T. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 71:777-789; 1992.
50. Thanos, D.; Maniatis, T. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83:1091-1100; 1995.
51. Ting, J. P.-Y.; Baldwin, A. S. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8-16; 1993.
52. Tjian, R.; Maniatis, T. Transcriptional activation: A complex puzzle with few easy pieces. Cell 77:5-8; 1994.
53. Van Dam, H.; Duyndam, M.; Rottier, R.; Bosch, A.; de Vries-Smits, L.; Herrlich, P.; Zantema, A.; Angel, P.; van der Eb, A. J. Heterodimer formation of c-Jun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12: 479-487; 1993.
54. Verma., I. M.; Stevenson, J. K.; Schwarz, E. M.; Van Antwerp, D.; Miyamoto, S. Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes Dev. 9:2723-2735; 1995.
55. Wang, H.-G. H.; Draetta, G.; Moran, E. E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products. Mol. Cell. Biol. 11:4253-4265; 1991.
56. Wang, H.-G. H.; Yaciuk, P.; Ricciardi, R. P.; Green, M.; Yokoyama, K.; Moran, E. The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300. J. Virol. 67:4804-4813; 1993.
57. Yano, O.; Kanellopoulos, J.; Kieran, M.; Le Bail, O.; Israel, A.; Kourilsky, P. Purification of KBF1, a common factor binding to both H-2 and β2-microglobulin enhancers. EMBO J. 6:3317-3324; 1987.
58. Yamit-Hezi, A.; Plaksin, D.; Eisenbach, L. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression. Oncogene 9:1065-1079; 1994.